`Filed: May 10, 2017
`
`
`Filed on behalf of: Sumitomo Dainippon Pharma Co., Ltd.
`
`By: Preston K. Ratliff II (PH-Par-Sunovion-IPR@paulhastings.com)
`
`Joseph M. O’Malley, Jr. (PH-Par-Sunovion-IPR@paulhastings.com)
`
`Naveen Modi (PH-Par-Sunovion-IPR@paulhastings.com)
`
`Michael A. Stramiello, Ph.D. (PH-Par-Sunovion-IPR@paulhastings.com)
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`PAR PHARMACEUTICAL, INC.,
`Petitioner
`
`v.
`
`SUMITOMO DAINIPPON PHARMA CO., LTD.,
`Patent Owner
`
`
`
`
`Case IPR2017-01292
`U.S. Patent No. 9,555,027
`
`
`
`PATENT OWNER’S EXHIBIT LIST
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2017-01292
`
`US. Patent 9,555,027
`
` 2001
`
`Declaration of Joseph M. O’Malley Jr.
`
`Date: May 10, 2017
`
`Respectfully submitted,
`
`/Preston K. Ratliff 11/
`Preston K- Ratliff 11, Reg. No. 43,034
`Naveen Modi, Reg. No. 46,224
`Joseph M. O’Malley, Jr. (pro hac vice pending)
`Michael A. Stramiello, Ph.D., Reg. No. 67,195
`
`Counsel for Patent Owner
`
`
`
`Case IPR2017-01292
`U.S. Patent 9,555,027
`
`CERTIFICATE OF SERVICE
`
`
`
`I hereby certify that on May 10, 2017, a copy of the foregoing Patent
`
`Owner’s Exhibit List was served by e-mail on the following counsel of record for
`
`Petitioner:
`
`Daniel G. Brown (daniel.brown@lw.com)
`Jonathan M. Strang (jonathan.strang@lw.com)
`
`Respectfully submitted,
`
`/Preston K. Ratliff II/
`Preston K. Ratliff II, Reg. No. 43,034
`Naveen Modi, Reg. No. 46,224
`Joseph M. O’Malley, Jr. (pro hac vice pending)
`Michael A. Stramiello, Ph.D., Reg. No. 67,195
`
`Counsel for Patent Owner
`
`
`
`
`
`
`Date: May 10, 2017
`
`
`
`
`
`
`
`
`
`